An interventional study of Cryoablation of Intercostal Nerves and Standard surgical treatment of patients with multiple rib fractures in Pain, Postoperative and Rib Fracture Multiple, sponsored by Wake Forest University Health Sciences. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Pain, Postoperative by Wake Forest University Health Sciences — 2 open to participants now, 3 under way, 1 of them phase 3. Pain, Postoperative · Wake Forest University Health Sciences.
Among the 15 studies in Pain, Postoperative by Wake Forest University Health Sciences, this one is the 4th largest by planned enrollment of the 14 interventional ones that give a count, is one of 3 that started in 2022, is one of 4 with no phase, and was the 13th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →2 of the 15 studies in Pain, Postoperative by Wake Forest University Health Sciences are open now, in 1 country. Recruiting first, the newest first:
Wake Forest University Health Sciences · Sites in United States
Ages 18–75
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 2 · Phase 4 4
First in 2011; this study’s year is marked. 3 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 63 across the 14 interventional studies, 179 across the 1 observational. Of the 9 that completed or were terminated, 7 (78%) have results posted.
This tab as a report to print or save as PDF → With an account.
Wake Forest University Health Sciences is the lead sponsor of 1,353 studies on the registry; 199 are open to participants now.
Of its 332 completed or terminated interventional studies of FDA-regulated products, 251 (76%) have results posted.
1 of the studies in Pain, Postoperative by Wake Forest University Health Sciences that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05415384Wake Forest University Health SciencesRandomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures | 2027-05 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Pain, Postoperative by Wake Forest University Health Sciences, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of Surgical Stabilization of Rib Fractures (SSRF) without cryoablation
Locoregional pain control with cryoneurolysis of intercostal nerves has been employed as an adjunct for longer term pain control. Initially introduced in thoracic surgery, intercostal nerve cryoablation has demonstrated adequate pain control and substantial decrease in opioid consumption and hospital length of stay.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adding Cryoablation of levels 3-8, in addition to patients that undergo SSRF for multiple rib fractures.
Device: Cryoablation of Intercostal Nerves
Standard surgical treatment of patients with multiple rib fractures plus Multimodal Pain Therapy
Procedure: Standard surgical treatment of patients with multiple rib fractures
Using Atricure device, cryoice, intercostal nerves 3-8 will be ablated in the experimental arm. This is in addition to mechanical fixation of rib fractures and multimodal systemic therapy.
Standard surgical treatment of patients with multiple rib fractures
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Time frame: Baseline
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Time frame: Day 1
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Time frame: Day 30
Morphine Milligram Equivalents Use following Intervention
To determine if patients with intraoperative cryoablation have better analgesia results compared to the control group of SSRF without cryoablation.
Time frame: Day 90
Number of days in Hospital Stay
Hospital Length of Stay
Time frame: Days during admission
Number of days in ICU Stay
ICU Length of Stay
Time frame: Day 90
Amount of Chest tube drainage
Chest tube drainage
Time frame: Day 90
Quality of Life Scores
Quality of Life questionnaire - Quality of life questionnaire consists of a set of survey questions that can be used to collect data related to an individual in particular and society in general on various parameters that determine their general quality of life
Time frame: Month 1 and Month 3
Number of Mortalities in hospital
Mortality, in hospital
Time frame: Day 90
Number of Readmissions
Readmission
Time frame: 30 day readmission rate
Number of Additional Thoracic Procedures
Additional Thoracic Procedures
Time frame: Day 7
Plan to share: No
No publications or documents are linked to this record.
Started Aug 2022 (actual). Primary completion is estimated for May 2027, 57 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 57 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Nov 2026 → May 2027 and completion Nov 2026 → May 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wake Forest University Health Sciences →